0

Heart Failure Collection
 21-40 of 42 Articles
ACP Journal Club |  16 August 2011
Review: Cardiac resynchronization reduces mortality and hospitalizations in patients with either more or less symptomatic HF
Adrian F. Hernandez, MD, MHS
Ann Intern Med. 2011;155(4):JC2-7. doi:10.7326/0003-4819-155-4-201108160-02007
ACP Journal Club |  19 July 2011
Bolus and continuous/high- and low-dose diuretics had similar effects on symptoms and renal function in acute, decompensated HF
Nishant Nerella, MD
Ann Intern Med. 2011;155(2):JC1-5. doi:10.7326/0003-4819-155-2-201107190-02005
ACP Journal Club |  17 May 2011
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions
Reem Mustafa, MD, MPH; Amit X. Garg, MD, PhD
Ann Intern Med. 2011;154(10):JC5-5. doi:10.7326/0003-4819-154-10-201105170-02005
ACP Journal Club |  15 March 2011
Telemonitoring did not reduce readmissions or mortality in patients recently hospitalized for heart failure
Robert K. Riezebos, MD
Ann Intern Med. 2011;154(6):JC3-8. doi:10.7326/0003-4819-154-6-201103150-02008
ACP Journal Club |  21 December 2010
In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone
Amy T. Wang, MD; Steven A. Smith, MD
Ann Intern Med. 2010;153(12):JC6-11. doi:10.7326/0003-4819-153-12-201012210-02011
ACP Journal Club |  20 July 2010
Adding NT-proBNP–guided management to multidisciplinary care reduced heart failure rehospitalization days
Bertram Pitt, MD
Ann Intern Med. 2010;153(2):JC1-8. doi:10.7326/0003-4819-153-2-201007200-02008
ACP Journal Club |  20 July 2010
Review: Therapy guided by B-type natriuretic peptide levels reduces mortality in chronic heart failure
Rosa Roccaforte, MD
Ann Intern Med. 2010;153(4):JC2-3. doi:10.7326/0003-4819-153-4-201008170-02003
ACP Journal Club |  20 April 2010
Review: Statins do not reduce mortality in patients with heart failure
Christopher B. Granger, MD; Chetan B. Patel, MD
Ann Intern Med. 2010;152(8):JC4-6. doi:10.7326/0003-4819-152-8-201004200-02006
ACP Journal Club |  20 April 2010
Male gender, diabetes, COPD, anemia, and creatinine clearance < 30 mL/min predicted hospitalization after heart failure diagnosis
Bertram Pitt, MD
Ann Intern Med. 2010;152(8):JC4-2. doi:10.7326/0003-4819-152-8-201004200-02002
ACP Journal Club |  20 April 2010
Review: Remote patient monitoring of patients with heart failure reduces mortality and heart failure admissions
Bertram Pitt, MD
Ann Intern Med. 2010;152(8):JC4-3. doi:10.7326/0003-4819-152-8-201004200-02003
ACP Journal Club |  20 April 2010
NT-proBNP–guided and clinically guided treatment reduced short-term but not long-term mortality in chronic HF
Sabesan Karuppiah, MD, DFM; Stephen A. Wilson, MD, MPH; Keiichiro Narumoto, MD
Ann Intern Med. 2010;152(8):JC4-4. doi:10.7326/0003-4819-152-8-201004200-02004
ACP Journal Club |  16 April 2010
Ferric carboxymaltose improved symptoms and quality of life in patients with chronic heart failure and iron deficiency
Robb D. Kociol, MD; L. Kristin Newby, MD, MHS
Ann Intern Med. 2010;152(8):JC4-5. doi:10.7326/0003-4819-152-8-201004200-02005
ACP Journal Club |  19 January 2010
A model combining clinical assessment and NT-proBNP level accurately predicted heart failure in ED patients with dyspnea
James Brophy, MD, PhD
Ann Intern Med. 2010;152(2):JC1-13. doi:10.7326/0003-4819-152-2-201001190-02013
ACP Journal Club |  16 June 2009
Use of nonsteroidal antiinflammatory drugs was associated with increased risks for death and hospitalization for MI and HF
David Siegel, MD, MPH
Ann Intern Med. 2009;150(12):JC6-12. doi:10.7326/0003-4819-150-12-200906160-02012
ACP Journal Club |  19 May 2009
Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fraction
Justin A. Ezekowitz, MD; Finlay A. McAlister, MD
Ann Intern Med. 2009;150(10):JC5-10. doi:10.7326/0003-4819-150-10-200905190-02010
ACP Journal Club |  17 March 2009
Review: Perioperative β-blockers provide no clear benefit in patients having noncardiac surgery
Ryan J. McColl, MD; Elijah Dixon, MD
Ann Intern Med. 2009;150(6):JC3-4. doi:10.7326/0003-4819-150-6-200903170-02004
ACP Journal Club |  20 January 2009
n-3 polyunsaturated fatty acids reduced morbidity and mortality in chronic heart failure
James M. Brophy, MD, PhD
Ann Intern Med. 2009;150(2):JC1-11. doi:10.7326/0003-4819-150-2-200901200-02011
ACP Journal Club |  21 October 2008
Rhythm control and rate control did not differ for CV mortality in atrial fibrillation and congestive heart failure
John Cairns, MD
Ann Intern Med. 2008;149(8):JC4-8. doi:10.7326/0003-4819-149-8-200810210-02008
ACP Journal Club |  16 September 2008
Review: Celecoxib increases risk for cardiovascular events; risks are greatest with higher doses
Bruce Rothschild, MD
Ann Intern Med. 2008;149(6):JC3-15. doi:10.7326/0003-4819-149-6-200809160-02015
ACP Journal Club |  17 June 2008
Evidence-based medicine targets the individual patient. Part 1: How clinicians can use study results to determine optimal individual care
Dirk Bassler, MD, MSc; Jason W. Busse, DC, MSc; Paul J. Karanicolas, MD, PhD; et al.
Ann Intern Med. 2008;148(12):JC4-2. doi:10.7326/0003-4819-148-12-200806170-02002
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)